// App-Quantinova.ai

e21643 : Safety of histamine H2 blocker concomitant administration in patients treated with high dose methotrexate regimen.

Researchers

Presenter

  • Yun Jung Choi

Principal Investigators

  • Ji Sung Lee

  • Tae Won Kim

  • Cheolwon Suh

  • Dok Hyun Yoon

  • Jeong Eun Kim

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Primary central nervous system lymphoma

  • Osteosarcoma

  • Lymphomas

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Methotrexate

  • Doxorubicin

  • Cytarabine liposomal

  • histamine

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved